HEAT BIOLOGICS INC Chart calendar Heat Biologics Inc
5d829c742a997dcb7b2c8.dB2TOfmeoYglIQSpyZOrHfOF-YwAfv-iNhAMw-VVZnI.N37xTsHN7Od9Z2_wv_Tmc73qo89MGpqWcmRakNNkAT8zcMNIra776Xx3bw~0203d986bb2d8660914307279935177c
Upcoming events on Heat Biologics Inc
Past events on Heat Biologics Inc
| Today | Q1 2024 Earnings Release (Projected) |
| 27/03/2024 | Q4 2023 Earnings Release |
| 20/11/2023 21:05 | Q3 2023 Earnings Release |
| 27/09/2023 15:00 | Annual General Meeting |
| 14/08/2023 21:05 | Q2 2023 Earnings Release |
| 15/05/2023 21:05 | Q1 2023 Earnings Release |
| 31/03/2023 21:05 | Q4 2022 Earnings Release |
| 14/11/2022 21:01 | Q3 2022 Earnings Release |
| 15/09/2022 15:00 | Annual General Meeting |
| 10/08/2022 21:05 | Interim 2022 Earnings Release |
| 19/05/2022 16:30 | Treg Directed Therapies Summit - Panel |
| 18/05/2022 21:30 | Treg Directed Therapies Summit |
| 16/05/2022 21:44 | Q1 2022 Earnings Release |
| 19/04/2022 15:30 | Investor Meeting |
| 14/03/2022 12:00 | FY 2021 Earnings Release |
| 25/02/2022 19:30 | Aegis Capital Virtual Summit |
| 04/01/2022 | LifeSci Partners Corporate Access Event |
| 10/11/2021 21:05 | Q3 2021 Earnings Release |
| 29/09/2021 14:20 | Cantor Fitzgerald Global Healthcare Conference |
| 15/09/2021 15:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,05 1,67 82.95% | 2,95 2,69 9.62% | 2,11 1,94 8.91% | 6,38 6,90 -7.49% | 6,99 4,90 42.75% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -20,7 -20,8 0.12% | -23,9 -25,5 6.29% | -34,0 -29,9 -13.7% | -45,7 -34,9 -30.91% | -42,0 -44,8 6.18% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,3 -21,9 6.92% | -26,4 -27,5 4.23% | -35,5 -29,8 -19.26% | -47,2 -36,4 -29.54% | -42,3 -44,8 5.51% |
|
Net income Million USD | Released Forecast Spread | -20,0 -21,2 5.44% | -26,0 -26,8 2.86% | -35,1 -29,3 -19.5% | -43,4 -35,0 -24.1% | -45,2 -44,4 -1.84% |
|
EPS USD | Released Forecast Spread | -4,20 -4,41 4.76% | -1,63 -1,23 -32.88% | -1,41 -1,19 -18.74% | -1,70 -1,36 -25% | -1,74 -1,58 -10.13% |
| Announcement Date | 30/03/20 | 25/03/21 | 11/03/22 | 31/03/23 | 26/04/24 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,61 0,44 39.34% | 0,21 0,60 -64.6% | 0,05 1,15 -95.57% | 0,06 0,97 -93.91% | 0,08 0,60 -86.68% | 0,77 0,12 566% | 0,66 0,90 -26.91% | 0,72 1,60 -54.8% | 4,85 1,90 155.16% |
|
EBIT Million USD | Released Forecast Spread | -12,0 -8,13 -48.24% | -7,48 -12,4 39.71% | -9,71 -7,55 -28.65% | -9,50 -9,10 -4.36% | -15,5 -11,1 -39.66% | -14,3 -11,9 -20.3% | -11,1 -9,50 -16.42% | -6,44 -7,70 16.43% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,8 -8,14 -68.92% | -8,19 -11,7 30% | -10,3 -7,75 -32.44% | -13,3 -9,00 -47.9% | -15,4 -11,0 -39.88% | -14,5 -11,8 -23.16% | -11,2 -9,40 -19.22% | -6,51 -7,70 15.49% | |
|
Net income Million USD | Released Forecast Spread | -13,6 -8,08 -67.95% | -8,12 -11,7 30.59% | -10,2 -7,75 -31.06% | -13,0 -9,00 -44.44% | -12,2 -11,0 -10.47% | -13,9 -11,7 -18.74% | -13,1 -9,30 -41.21% | -5,41 -7,60 28.84% | |
|
EPS USD | Released Forecast Spread | -0,54 -0,32 -68.75% | -0,32 -0,44 26.72% | -0,40 -0,30 -33.33% | -0,51 -0,35 -45.71% | -0,48 -0,43 -11.63% | -0,53 -0,45 -17.78% | -0,50 -0,35 -42.86% | -0,21 -0,22 4.55% | |
| Announcement Date | 11/03/22 | 16/05/22 | 10/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 20/11/23 | 26/04/24 |
More events
